Eli Lilly and Co (LLY)

767.76 +10.22 (+1.35%) USD  |  NYSE  |  Dec 20, 16:00
783.89 +16.13 (+2.10%) Pre-Market: 04:27
More

Eli Lilly Research and Development Expense (% of Annual Revenues)

Research and Development Expense (% of Annual Revenues) Chart

View Research and Development Expense (% of Annual Revenues) for LLY.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (% of Annual Revenues) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

R&D Expense Definition

View R&D Expense Definition
Start Trial

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (% of Annual Revenues) Range, Past 5 Years

View Research and Development Expense (% of Annual Revenues) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (% of Annual Revenues) Benchmarks

View Research and Development Expense (% of Annual Revenues) Benchmarks
Start Trial
Amgen Inc Upgrade
Biogen Inc Upgrade
Regeneron Pharmaceuticals Inc Upgrade
Viking Therapeutics Inc --
Moderna Inc Upgrade